Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
10,246,869
-
Shares change
-
+9,562,494
-
Total reported value, excl. options
-
$86,073,000
-
Value change
-
+$80,324,000
-
Number of buys
-
12
-
Price
-
$8.40
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2015
14 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2015.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,246,869 shares
of 87,001,862 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include FMR LLC (3,113,719 shares), EcoR1 Capital, LLC (2,450,000 shares), Partner Fund Management, L.P. (1,494,169 shares), Clough Capital Partners L P (1,087,233 shares), FRANKLIN RESOURCES INC (970,171 shares), Boxer Capital, LLC (654,595 shares), VANGUARD GROUP INC (225,667 shares), Birchview Capital, LP (105,285 shares), Monashee Investment Management LLC (65,222 shares), and Partner Investment Management, L.P. (48,748 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.